Washington University/B-JH/SLCH Consortium at Missouri Baptist Medical Center
Internal Medicine residency · St. Louis, MO · Program website
Incomplete roster. Only leadership has been collected so far; most faculty couldn't be matched to publication records, so the marked trainee numbers may be off, and this program isn't compared with others until it's fixed. It's queued for another look. 7 people are also awaiting a match decision.
- 8
- Faculty
- 0*
- Trainees
- 1
- Papers
Papers
By this program's faculty and trainees since 2022, 1 in all. Updated 2026-11-07.
- Doctor’s LoungeVinay Kamat · Annals of Internal Medicine · 2026 · PubMed
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Vinay Kamat, MD, FACP | Endocrinology, Diabetes and Metabolism | 1 | 1 | 1 | 0 | — |
| Alex Li, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Bahaa Bedair, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Christopher Lynch, MD, FACP (unresolved) | — | — | 0 | 0 | 0 | — |
| Daniel Goodenberger, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Kelsey Moon, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Michael Fuller, MD, FACP (unresolved) | — | — | 0 | 0 | 0 | — |
| Rebecca Wiesehan, MD (unresolved) | — | — | 0 | 0 | 0 | — |
About Missouri Baptist Medical Centerinstitution-wide internal medicine research
Internal Medicine publications from Missouri Baptist Medical Center and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Internal Medicine research topics at Missouri Baptist Medical Center
Papers in the window; each links to the list on OpenAlex.
Most cited at Missouri Baptist Medical Center since 2024
All internal medicine papers there on OpenAlex
- Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929Nagla Abdel Karim et al. · Journal of Thoracic Oncology · 2024 · PubMed · cited 44
- Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon CancerFrank A. Sinicrope et al. · New England Journal of Medicine · 2026 · PubMed · cited 30
- A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19Manu Shankar‐Hari et al. · JCI Insight · 2025 · PubMed · cited 24
- PRAGMATICA-LUNG (SWOG S2302): A prospective, randomized study of ramucirumab plus pembrolizumab versus standard of care for participants previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer.Konstantin H. Dragnev et al. · Journal of Clinical Oncology · 2025 · cited 13
- Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)Howard S. Höchster et al. · JNCI Journal of the National Cancer Institute · 2024 · PubMed · cited 10
- Prospective Audit and Feedback by Antibiotic Stewardship Teams to Reduce Antibiotic Overuse at Hospital DischargeDaniel J. Livorsi et al. · JAMA Network Open · 2026 · PubMed · cited 6
- Urinary Vacuolar Casts Are a Unique Type of Casts in Advanced Proteinuric GlomerulopathiesSarah Rosenbloom et al. · Kidney360 · 2024 · PubMed · cited 6
- Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair SystemThomas E. Waggoner et al. · JACC: Cardiovascular Interventions · 2025 · PubMed · cited 5
- Pacemaker syndrome: Thinking beyond atrioventricular dyssynchronyGabriel E. Soto · HeartRhythm Case Reports · 2024 · PubMed · cited 5
- PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical TrialsAllison M. Booth et al. · Journal of Thoracic Oncology · 2026 · PubMed · cited 3